戻る Agenda
SESSION 3
Session Chair(s)
Toshiyoshi Tominaga, PhD
Life Science Department, Advisor, Sunflare, Japan
Session 3
Speaker(s)
Pär Tellner, MPharm, MSc, RPh
Director, Regulatory Affairs, EFPIA, Belgium
Panel Discussion
Steven Teerenstra, PhD, MSc
Statistician, Medicines Evaluation Board, Netherlands
E9 Improving Planning, Conduct, Analysis and Interpretation of Clinical Trials
Corina Dana Dota, MD
AZ ECG Centre Director, AstraZeneca R&D Molndal, Sweden
E14 Clinical Evaluation of QT/QTc
Filip Mussen, PhD
Vice President, Regional Regulatory Affairs, Janssen R&D, Pharmaceutical Companies of Johnson & Johnson, Belgium
M4E (CTD) Benefit-Risk Information
Tomas Salmonson, DrMed, PhD
, Critical Path Institute, Netherlands
Panel Discussion